BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 20734147)

  • 1. Resection margins in ultrasound-guided breast-conserving surgery.
    Olsha O; Shemesh D; Carmon M; Sibirsky O; Abu Dalo R; Rivkin L; Ashkenazi I
    Ann Surg Oncol; 2011 Feb; 18(2):447-52. PubMed ID: 20734147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery.
    Cabioglu N; Hunt KK; Sahin AA; Kuerer HM; Babiera GV; Singletary SE; Whitman GJ; Ross MI; Ames FC; Feig BW; Buchholz TA; Meric-Bernstam F
    Ann Surg Oncol; 2007 Apr; 14(4):1458-71. PubMed ID: 17260108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound-guided excision combined with intraoperative assessment of gross macroscopic margins decreases the rate of reoperations for non-palpable invasive breast cancer.
    Ramos M; Díaz JC; Ramos T; Ruano R; Aparicio M; Sancho M; González-Orús JM
    Breast; 2013 Aug; 22(4):520-4. PubMed ID: 23110817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraoperative ultrasound reduces the need for re-excision in breast-conserving surgery.
    Karanlik H; Ozgur I; Sahin D; Fayda M; Onder S; Yavuz E
    World J Surg Oncol; 2015 Nov; 13():321. PubMed ID: 26596699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound-guided lumpectomy for palpable breast cancers.
    Fisher CS; Mushawah FA; Cyr AE; Gao F; Margenthaler JA
    Ann Surg Oncol; 2011 Oct; 18(11):3198-203. PubMed ID: 21861232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low re-excision rate for positive margins in patients treated with ultrasound-guided breast-conserving surgery.
    Yu CC; Chiang KC; Kuo WL; Shen SC; Lo YF; Chen SC
    Breast; 2013 Oct; 22(5):698-702. PubMed ID: 23333255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative ultrasound guidance in breast-conserving surgery shows superiority in oncological outcome, long-term cosmetic and patient-reported outcomes: Final outcomes of a randomized controlled trial (COBALT).
    Volders JH; Haloua MH; Krekel NM; Negenborn VL; Kolk RH; Lopes Cardozo AM; Bosch AM; de Widt-Levert LM; van der Veen H; Rijna H; Taets van Amerongen AH; Jóźwiak K; Meijer S; van den Tol MP
    Eur J Surg Oncol; 2017 Apr; 43(4):649-657. PubMed ID: 27916314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative margin assessment and re-excision rate in breast conserving surgery.
    Fleming FJ; Hill AD; Mc Dermott EW; O'Doherty A; O'Higgins NJ; Quinn CM
    Eur J Surg Oncol; 2004 Apr; 30(3):233-7. PubMed ID: 15028301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of breast cancer excision by intraoperative ultrasound and marking needle - technique description and feasibility.
    Ivanovic NS; Zdravkovic DD; Skuric Z; Kostic J; Colakovic N; Stojiljkovic M; Opric S; Stefanovic Radovic M; Soldatovic I; Sredic B; Granic M
    World J Surg Oncol; 2015 Apr; 13():153. PubMed ID: 25896818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of New Lumpectomy Margin Guidelines for Breast-Conserving Surgery: Changes in Reexcision Rates and Predicted Rates of Residual Tumor.
    Merrill AL; Coopey SB; Tang R; McEvoy MP; Specht MC; Hughes KS; Gadd MA; Smith BL
    Ann Surg Oncol; 2016 Mar; 23(3):729-34. PubMed ID: 26467458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal use of re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy.
    Caughran JL; Vicini FA; Kestin LL; Dekhne NS; Benitez PR; Goldstein NS
    Ann Surg Oncol; 2009 Nov; 16(11):3020-7. PubMed ID: 19636632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of Residual Tumor in Breast-Conserving Therapy.
    Rath MG; Uhlmann L; Heil J; Domschke C; Roth Z; Sinn HP; Marme F; Scharf A; Schneeweiss A; Kieser M; Sohn C; Rom J
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S451-8. PubMed ID: 26224405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of additional surgical margins on the total specimen volume excised and the reoperative rate after breast-conserving surgery.
    Huston TL; Pigalarga R; Osborne MP; Tousimis E
    Am J Surg; 2006 Oct; 192(4):509-12. PubMed ID: 16978962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive Factors for Positive Margin and the Surgical Learning Curve in Non-Palpable Breast Cancer After Wire-Guided Localization - Prospective Study of 214 Consecutive Patients.
    Tóth D; Varga Z; Sebő É; Török M; Kovács I
    Pathol Oncol Res; 2016 Jan; 22(1):209-15. PubMed ID: 26522009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Using Intra-Operative Ultrasound Guided Breast- Conserving Surgery on Positive Margin and Re-Excision Rates in Breast Cancer Cases with Current SSO/ASTRO Guidelines.
    Thanasitthichai S; Chaiwerawattana A; Phadhana-Anake O
    Asian Pac J Cancer Prev; 2016; 17(9):4463-4467. PubMed ID: 27797262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Influence of Repeat Surgery and Residual Disease on Recurrence After Breast-Conserving Surgery: A Danish Breast Cancer Cooperative Group Study.
    Bodilsen A; Bjerre K; Offersen BV; Vahl P; Ejlertsen B; Overgaard J; Christiansen P
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S476-85. PubMed ID: 26178760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Consensus Guidelines by the Society of Surgical Oncology and the American Society for Radiation Oncology on Margins for Breast-Conserving Surgery in Stages 1 and 2 Invasive Breast Cancer.
    Chung A; Gangi A; Amersi F; Bose S; Zhang X; Giuliano A
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S422-7. PubMed ID: 26310280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of re-excision for narrow or positive margins of invasive and intraductal carcinoma.
    Gupta A; Subhas G; Dubay L; Silapaswan S; Kolachalam R; Kestenberg W; Ferguson L; Jacobs MJ; Gorieil Y; Mittal VK
    Am Surg; 2010 Jul; 76(7):731-4. PubMed ID: 20698380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Margin width is not predictive of residual disease on re-excision in breast conserving therapy.
    Hadzikadic Gusic L; McGuire KP; Ozmen T; Soran A; Thomas CR; McAuliffe PF; Diego EJ; Bonaventura M; Johnson RR; Ahrendt GM
    J Surg Oncol; 2014 Apr; 109(5):426-30. PubMed ID: 24338603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety of multiple re-excisions after lumpectomy for breast cancer.
    Coopey S; Smith BL; Hanson S; Buckley J; Hughes KS; Gadd M; Specht MC
    Ann Surg Oncol; 2011 Dec; 18(13):3797-801. PubMed ID: 21630123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.